{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-147662","form_type":"8-K","ticker":"AMGN","cik":"0000318154","company_name":"AMGEN INC","filed_at":"2023-05-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.775702+00:00","generated_at":"2026-06-14T21:36:12.633847+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"FTC obtains stipulated TRO blocking Amgen's Horizon acquisition until Sept 15 or court ruling","bullets":["FTC filed complaint May 16, 2023 in N.D. Illinois seeking to enjoin $27.8B acquisition of Horizon Therapeutics.","Stipulated TRO granted May 17, 2023: Amgen and Horizon cannot close deal until Sept 15, 2023 or 2nd business day after court rules on FTC's preliminary injunction request.","Parties agreed to the stipulated TRO to allow court to consider the FTC's request."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-147662","json":"https://secwatch.observer/filing/0001193125-23-147662.json","markdown":"https://secwatch.observer/filing/0001193125-23-147662.md","text":"https://secwatch.observer/filing/0001193125-23-147662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318154/000119312523147662/0001193125-23-147662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318154/000119312523147662/d499865d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T21:36:12.633847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}